IP Library Granted Patent US 9,932,625
Granted Patent B2
US 9,932,625 · App. 14/387,150 · Granted Apr 3, 2018

Method for identification and detection of mutant gene using intercalator

Inventors: Shoichi Matsukuma (Yokohama, JP); Tomokazu Ishikawa (Amagasaki, JP); Tatsuo Kurosawa (Amagasaki, JP)
Assignees: WAKO PURE CHEMICAL INDUSTRIES, LTD.; KANAGAWA PREFECTURAL HOSPITAL ORGANIZATION
C12Q1/6823C12Q1/6827G01N2458/30
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,932,625
App. No.
14/387,150
Granted
Apr 3, 2018
Kind
B2
Abstract

The invention provides a method for detection of mutant-type DNA or/and wild-type DNA by contacting at least one of a single-stranded DNA having a substituted nucleotide, a deficient nucleotide region, or an inserted nucleotide region (mutant-type DNA), or/and a wild-type single-stranded DNA corresponding to the mutant-type DNA (wild-type DNA) with a probe hybridizing with both single-stranded DNAs, to form a hybrid with the mutant-type DNA (mutant-type hybrid) or/and a hybrid with the wild-type DNA (wild-type hybrid) (at least one of the obtained mutant-type hybrid and wild-type hybrid has a loop structure), (2) contacting the obtained mutant-type hybrid or/and wild-type hybrid with an intercalator, and (3) detecting the presence or absence of the mutant-type DNA or/and the wild-type DNA by separating the conjugate of mutant-type hybrid and intercalator or/and the conjugate of wild-type hybrid and intercalator.

Claims (30)

1. A method for detecting mutant-type DNA or/and wild-type DNA in a sample comprising the following steps (1) to (4):

(1) hybridizing a mutant single-stranded DNA with a probe to form a mutant-type hybrid, or/and hybridizing a wild-type single-stranded DNA with the probe to form a wild-type hybrid, wherein at least one of the mutant-type hybrid and the wild-type hybrid has a loop structure, and wherein the mutant single-stranded DNA has a different nucleotide sequence than the wild-type single-stranded DNA,

(2) contacting the mutant-type hybrid or/and the wild-type hybrid obtained in step (1) with an intercalator to form a mutant-type hybrid and intercalator conjugate or/and a wild-type hybrid and intercalator conjugate,

(3) separating the conjugate of mutant-type hybrid and intercalator or/and the conjugate of wild-type hybrid and intercalator from the sample, wherein the method for separating the conjugate of mutant-type hybrid and intercalator or/and the conjugate of wild-type hybrid and intercalator is an electrophoretic method, and

(4) detecting the presence or absence of the separated conjugate of mutant-type hybrid and intercalator or/and the separated conjugate wild-type hybrid and intercalator as determinative of the presence or absence of the mutant-type DNA or/and the wild-type DNA.

2. The method according to claim 1 , wherein the probe has a nucleotide that does not allow the probe to perfectly complement the mutant single-stranded DNA, thereby forming the loop structure or/and the probe has a nucleotide that does not allow the probe to perfectly complement the wild-type single-stranded DNA, thereby forming the loop structure.

3. The method according to claim 1 , wherein the loop structure further comprises a stem structure.

4. The method according to claim 1 , wherein the intercalator is selected from the group of an acridine dye, an ethidium compound, an iodine compound, 7-aminoactinomycin D (7-AAD), a cyanine dimer dye, a cyanine monomer dye, a dye that binds to the minor groove of a DNA double helix, and a dye that binds to an adenine-thymine sequence.

5. The method according to claim 1 , wherein the conjugate of mutant-type hybrid and intercalator or/and the conjugate of wild-type hybrid and intercalator is separated based on a difference of molecular weight, molecular structure, or electric charge.

6. The method according to claim 1 , wherein the probe perfectly complements a portion of the mutant single-stranded DNA over the entire length of the probe, which portion of the mutant single-stranded DNA has a nucleotide sequence that differs from that of the corresponding portion of the wild-type single-stranded DNA by containing one or more additional nucleotides, such that the wild-type hybrid has a loop structure.

7. The method according to claim 1 , wherein the probe perfectly complements a portion of the mutant single-stranded DNA over the entire length of the probe, which portion of the mutant single-stranded DNA has a nucleotide sequence that differs from that of the corresponding portion of the wild-type single-stranded DNA by containing one or more fewer nucleotides, such that the wild-type hybrid has a loop structure.

8. The method according to claim 1 , wherein the probe perfectly complements a portion of the wild-type single-stranded DNA over the entire length of the probe, which portion of the wild-type single-stranded DNA has a nucleotide sequence that differs from that of the corresponding portion of the mutant single-stranded DNA by containing one or more additional nucleotides, such that the mutant-type hybrid has a loop structure.

9. The method according to claim 1 , wherein the probe perfectly complements a portion of the wild-type single-stranded DNA over the entire length of the probe, which portion of the wild-type single-stranded DNA has a nucleotide sequence that differs from that of the corresponding portion of the mutant single-stranded DNA by containing one or more fewer nucleotides, such that the mutant-type hybrid has a loop structure.

10. The method according to claim 1 , wherein the probe does not perfectly complement a portion of the wild-type single-stranded DNA or a portion of the mutant single-stranded DNA over the entire length of the probe, and wherein the wild-type single-stranded DNA has one or more nucleotides that differ from corresponding nucleotides of the mutant single-stranded DNA, such that the wild-type hybrid has a loop structure and the mutant-type hybrid has a loop structure.

11. A method for detecting the presence or absence of a mutation in an epidermal growth factor receptor (EGFR) gene in a sample comprising the following steps (1) to (4):

(1) hybridizing a mutant single-stranded EGFR gene with a probe to form a mutant-type hybrid or/and hybridizing a wild-type single-stranded EGFR with the probe to form a wild-type hybrid,

wherein at least one of the mutant-type hybrid and the wild-type hybrid has a loop structure, and

wherein the mutant single-stranded DNA has a different nucleotide sequence than the wild-type single stranded DNA,

(2) contacting the mutant-type hybrid or/and the wild-type hybrid obtained in step (1) with an intercalator, to form a mutant-type hybrid and intercalator conjugate or/and a wild-type hybrid and intercalator conjugate,

(3) separating the conjugate of mutant-type hybrid and intercalator or/and the conjugate of wild-type hybrid and intercalator from the sample, wherein the method for separating the conjugate of mutant-type hybrid and intercalator or/and the conjugate of wild-type hybrid and intercalator is an electrophoretic method, and

(4) detecting the presence or absence of the separated conjugate of mutant-type hybrid and intercalator or/and the separated conjugate of wild-type hybrid and intercalator as determinative of the presence or absence of the mutant-type EGFR or/and the wild-type EGFR.

12. The method according to claim 11 , wherein the probe has a nucleotide that does not allow the probe to perfectly complement the mutant single-stranded EGFR, thereby forming the loop structure or/and the probe has a nucleotide that does not allow the probe to perfectly complement the wild-type single-stranded EGFR, thereby forming the loop.

13. The method according to claim 12 , wherein the probe comprises the nucleotide sequence of SEQ ID NO: 15.

14. A method for detecting the presence or absence of a mutation in a kirsten rat sarcoma viral oncogene (KRAS) gene in a sample comprising the following steps (1) to (4):

(1) hybridizing a mutant single-stranded KRAS gene with a probe to form a mutant-type hybrid or/and hybridizing a wild-type single-stranded KRAS with the probe to form a wild-type hybrid, wherein at least one of the mutant-type hybrid and the wild-type hybrid has a loop structure, and wherein the mutant single-stranded DNA has a different nucleotide sequence than the wild-type single stranded DNA,

(2) contacting the mutant-type hybrid or/and the wild-type hybrid obtained in step (1) with an intercalator, to form a mutant-type hybrid and intercalator conjugate or/and a wild-type hybrid and intercalator conjugate,

(3) separating the conjugate of mutant-type hybrid and intercalator or/and the conjugate of wild-type hybrid and intercalator from the sample, wherein the method for separating the conjugate of mutant-type hybrid and intercalator or/and the conjugate of wild-type hybrid and intercalator is an electrophoretic method, and

(4) detecting the presence or absence of the separated conjugate of mutant-type hybrid and intercalator or/and the separated conjugate of wild-type hybrid and intercalator as determinative of the mutant-type KRAS or/and the wild-type KRAS.

15. The method according to claim 14 , wherein the probe has a nucleotide that does not allow the probe to perfectly complement the mutant single-stranded KRAS, thereby forming the loop structure or/and the probe has a nucleotide that does not allow the probe to perfectly complement the wild-type single-stranded KRAS, thereby forming the loop.

16. The method according to claim 15 , wherein the probe comprises the nucleotide sequence of SEQ ID NO: 19.

Assignments (3)
CHANGE OF NAME Recorded Jun 13, 2018
From: WAKO PURE CHEMICAL INDUSTRIES, LTD.
To: FUJIFILM WAKO PURE CHEMICAL CORPORATION
Reel/Frame 046075/0270 →
CORRECTIVE ASSIGNMENT TO CORRECT THE THIRD INVENTOR'S NAME PREVIOUSLY RECORDED AT REEL: 033792 FRAME: 0631. ASSIGNOR(S) HEREBY CONFIRMS THE ASSIGNMENT . Recorded Jan 25, 2018
From: MATSUKUMA, SHOICHI; ISHIKAWA, TOMOKAZU; KUROSAWA, TATSUO
To: WAKO PURE CHEMICAL INDUSTRIES, LTD.; KANAGAWA PREFECTURAL HOSPITAL ORGANIZATION
Reel/Frame 045150/0970 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Sep 22, 2014
From: MATSUKUMA, SHOICHI; ISHIKAWA, TOMOKAZU; KOROSAWA, TATSUO
To: WAKO PURE CHEMICAL INDUSTRIES, LTD.; KANAGAWA PREFECTURAL HOSPITAL ORGANIZATION
Reel/Frame 033792/0631 →
Priority Claims (1)
JP 2012-065231 · Mar 22, 2012 · national
Continuity (1)
Related Publication 20150050749A1 · Feb 19, 2015